Moderna offers NIH co-ownership of COVID vaccine patent

The National Institutes of Health said Monday it has engaged Moderna in “good faith discussions” to resolve a monthslong dispute over the company’s patent application that advocates say could impact global production of the shots. 

Moderna is offering to share ownership of its COVID-19 vaccine patent with the U.S. government to resolve the dispute, the vaccine maker said, and would allow the Biden administration to “license the patents as they see fit.”